These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 11873724)

  • 1. [Breakthrough in thrombosis prevention?].
    Hassenpflug J
    Dtsch Med Wochenschr; 2002 Feb; 127(6):249. PubMed ID: 11873724
    [No Abstract]   [Full Text] [Related]  

  • 2. [Standard prevention of thrombosis in hip and knee alloplasties].
    Thomsen PB
    Ugeskr Laeger; 2001 Feb; 163(7):937-8. PubMed ID: 11228795
    [No Abstract]   [Full Text] [Related]  

  • 3. [Pharmaceutical prevention of thrombosis after knee and hip replacement surgery].
    Paulsen PQ
    Tidsskr Nor Laegeforen; 1997 Nov; 117(28):4131. PubMed ID: 9441453
    [No Abstract]   [Full Text] [Related]  

  • 4. [Prevention of thrombosis in hip alloplasty].
    Borris LC; Petersen MB; Lassen MR
    Ugeskr Laeger; 2001 Feb; 163(7):934; discussion 934-5. PubMed ID: 11228793
    [No Abstract]   [Full Text] [Related]  

  • 5. [Thrombosis prevention after hip arthroplasty].
    Andreassen G; Dahl OE
    Tidsskr Nor Laegeforen; 1998 Mar; 118(7):1099. PubMed ID: 9531839
    [No Abstract]   [Full Text] [Related]  

  • 6. [Thromboprophylaxis in hip and knee arthroplasty. Are the new anticoagulants better than those previously used?].
    Nielsen JD
    Ugeskr Laeger; 2005 May; 167(21):2261-5. PubMed ID: 15962850
    [No Abstract]   [Full Text] [Related]  

  • 7. [Reflexions on the most appropriate approach with low-weight heparins for antithrombotic prophylaxis in hip and knee arthroplasty].
    Iturbe Hernández T; de Miguel Olmeda R; Cornudella Lacasa R; Gutiérrez Martín M
    An Med Interna; 2001 Jan; 18(1):45-6. PubMed ID: 11387846
    [No Abstract]   [Full Text] [Related]  

  • 8. Regarding "Acute arterial complications associated with total hip and knee arthroplasty".
    Oremus K
    J Vasc Surg; 2004 May; 39(5):1148; author reply 1148. PubMed ID: 15134092
    [No Abstract]   [Full Text] [Related]  

  • 9. [The cost-effectiveness of fondaparinux compared to enoxaparin as prophylaxis for deep-vein thrombosis in Denmark].
    Olsen J; Gundgaard J; Borris LC
    Ugeskr Laeger; 2005 May; 167(21):2273-9. PubMed ID: 15962854
    [No Abstract]   [Full Text] [Related]  

  • 10. Venous thromboembolic disease after total hip and knee arthroplasty: current perspectives in a regulated environment.
    Pellegrini VD; Sharrock NE; Paiement GD; Morris R; Warwick DJ
    Instr Course Lect; 2008; 57():637-61. PubMed ID: 18399613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Total hip and knee arthroplasty: do obese patients or smokers require a more prolonged thrombosis prophylaxis?].
    Iturbe Hernández T; de Miguel Olmeda R; Cornudella Lacasa R; Gutiérrez Martín M
    Rev Clin Esp; 1999 Aug; 199(8):550-1. PubMed ID: 10522444
    [No Abstract]   [Full Text] [Related]  

  • 12. [Analysis of the cost effectiveness ratio of an autotransfusion program for primary prosthetic knee and hip surgery].
    Muñoz Gómez M; García-Vallejo JJ; Clavero Barranquero A; López-Andrade Jurado A; Ruiz Romero de la Cruz MD
    Rev Esp Anestesiol Reanim; 2001 Jan; 48(1):43-4. PubMed ID: 11234608
    [No Abstract]   [Full Text] [Related]  

  • 13. [Fondaparinux--a good therapeutic alternative. Interesting pharmacological action for thrombosis prevention in orthopedic surgery].
    Bergqvist D
    Lakartidningen; 2005 Jan 17-23; 102(3):104-5. PubMed ID: 15712733
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical risk factors for deep vein thrombosis after total hip and knee arthroplasty].
    Guan ZP; Lü HS; Chen YZ; Song YN; Qin XL; Jiang J
    Zhonghua Wai Ke Za Zhi; 2005 Oct; 43(20):1317-20. PubMed ID: 16271243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Venous thrombosis prophylaxis with low-molecular-weight heparin in hip and knee arthroplasty.
    Colwell CW
    Instr Course Lect; 2002; 51():487-9. PubMed ID: 12064138
    [No Abstract]   [Full Text] [Related]  

  • 16. Recent developments in the use of oral anticoagulants.
    Lassen MR
    Expert Opin Pharmacother; 2009 Aug; 10(11):1769-81. PubMed ID: 19548861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extended prophylaxis of venous thromboembolism in major orthopaedic surgery.
    Verhaeghe R
    Acta Orthop Belg; 2005 Jun; 71(3):255-9. PubMed ID: 16035696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A clinical algorithm to predict the loading dose of phenprocoumon.
    Good AC; Henz S
    Thromb Res; 2007; 120(6):921-5. PubMed ID: 17350082
    [No Abstract]   [Full Text] [Related]  

  • 19. Xarelto: a new drug for new joints. Hip and knee recipients can avoid postsurgical clots without undergoing painful injections.
    Johns Hopkins Med Lett Health After 50; 2011 Oct; 23(8):6. PubMed ID: 22059258
    [No Abstract]   [Full Text] [Related]  

  • 20. Ximelagatran for the prevention of venous thromboembolism following elective hip or knee replacement surgery.
    Colwell C; Mouret P
    Semin Vasc Med; 2005 Aug; 5(3):266-75. PubMed ID: 16123914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.